Specifically, CXCL3 drives the transformation of CAFs into myofibroblastic CAFs, facilitating tumor metastasis [41], whereas CXCL8 promotes tumor cell proliferation, EMT, and an immunosuppressive tumor microenvironment [42]. Here, CXCL8 is linked to neoplasm.